Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas - a single centre experience.

Boltezar L, Pintaric K, Pretnar J, Pohar Perme M, Novakovic BJ.

Radiol Oncol. 2016 Jun 24;51(1):81-87. doi: 10.1515/raon-2016-0040. eCollection 2017 Mar 1.

2.

Outcome of severe infections in afebrile neutropenic cancer patients.

Strojnik K, Mahkovic-Hergouth K, Novakovic BJ, Seruga B.

Radiol Oncol. 2016 Feb 10;50(4):442-448. eCollection 2016 Dec 1.

3.
4.

Changes in expression of genes involved in antitumor immunity in mice vaccinated with tumor vaccine composed of irradiated syngeneic tumor cells and CpG oligodeoxynucleotides.

Cerkovnik P, Novaković BJ, Stegel V, Novaković S.

Mol Immunol. 2016 Nov;79:1-13. doi: 10.1016/j.molimm.2016.09.016. Epub 2016 Sep 24.

5.

The impact of FcγRIIa and FcγRIIIa gene polymorphisms on responses to RCHOP chemotherapy in diffuse large B-cell lymphoma patients.

Rožman S, Novaković S, Grabnar I, Cerkovnik P, Novaković BJ.

Oncol Lett. 2016 May;11(5):3332-3336. Epub 2016 Apr 1.

6.

Immunotoxin - a new treatment option in patients with relapsed and refractory Hodgkin lymphoma.

Novakovic BJ.

Radiol Oncol. 2015 Nov 27;49(4):315-9. doi: 10.1515/raon-2015-0036. eCollection 2015 Dec. Review.

7.

Clonality analysis of lymphoid proliferations using the BIOMED-2 clonality assays: a single institution experience.

Kokovic I, Novakovic BJ, Cerkovnik P, Novakovic S.

Radiol Oncol. 2014 Apr 25;48(2):155-62. doi: 10.2478/raon-2013-0072. eCollection 2014 Jun.

8.

Late-onset neutropenia following primary treatment of diffuse large B-cell lymphoma with rituximab-containing therapy.

Rozman S, Sonc M, Novakovic BJ.

Leuk Lymphoma. 2012 Oct;53(10):1945-8. doi: 10.3109/10428194.2012.679266. Epub 2012 May 21.

PMID:
22563814
9.

Eleven years of experience with AIDS-related lymphomas at the Institute of Oncology Ljubljana.

Mesti T, Setina TJ, Vovk M, Novaković BJ.

Med Oncol. 2012 Jun;29(2):1217-22. doi: 10.1007/s12032-011-9951-7. Epub 2011 Apr 24.

PMID:
21516485
10.

The predictive significance of CD20 expression in B-cell lymphomas.

Prevodnik VK, Lavrenčak J, Horvat M, Novakovič BJ.

Diagn Pathol. 2011 Apr 12;6:33. doi: 10.1186/1746-1596-6-33.

11.

Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma.

Horvat M, Novakovic BJ.

Radiol Oncol. 2010 Dec;44(4):232-8. doi: 10.2478/v10019-010-0044-6. Epub 2010 Oct 14.

12.

Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity.

Cerkovnik P, Novakovic BJ, Stegel V, Novakovic S.

BMC Immunol. 2010 Sep 13;11:45. doi: 10.1186/1471-2172-11-45.

14.

Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs.

Novaković S, Stegel V, Kopitar A, Ihan A, Novaković BJ.

Vaccine. 2007 Nov 28;25(49):8241-56. Epub 2007 Oct 17.

PMID:
17980936
15.

Supplemental Content

Loading ...
Support Center